These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6325716)

  • 1. Effect of palmitoyl carnitine on Na+, K+-ATPase and adenylate cyclase activity of canine myocardial sarcolemma.
    Abe M; Yamazaki N; Suzuki Y; Kobayashi A; Ohta H
    J Mol Cell Cardiol; 1984 Mar; 16(3):239-45. PubMed ID: 6325716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of palmitoyl carnitine and LPC on cardiac sarcolemmal Na+-K+-ATPase.
    Pitts BJ; Okhuysen CH
    Am J Physiol; 1984 Nov; 247(5 Pt 2):H840-6. PubMed ID: 6093598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of sarcolemmal Na+-K+-ATPase by palmitoyl carnitine: potentiation by propranolol.
    Kramer JH; Weglicki WB
    Am J Physiol; 1985 Jan; 248(1 Pt 2):H75-81. PubMed ID: 2982278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of fatty acid intermediates on Na+-K+-ATPase activity of cardiac sarcolemma.
    Owens K; Kennett FF; Weglicki WB
    Am J Physiol; 1982 Mar; 242(3):H456-61. PubMed ID: 6278956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of lipid intermediates on Ca2+ and Na+ permeability and (Na+ + K+)-ATPase of cardiac sarcolemma. A possible role in myocardial ischemia.
    Lamers JM; Stinis HT; Montfoort A; Hülsmann WC
    Biochim Biophys Acta; 1984 Jul; 774(1):127-37. PubMed ID: 6329291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of membrane integrity and cation interaction for heart sarcolemmal adenylate cyclase and Na+-K+ ATPase.
    Chauhan MS; Anand-Srivastava MB; Panagia V; Dhalla NS
    Adv Myocardiol; 1982; 3():317-27. PubMed ID: 6302775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence against a regulation of Na+/K(+)-ATPase by Gi proteins. Failure to detect an influence of G proteins on Na+/Ca(2+)-exchange in cardiac sarcolemmal membranes.
    Mura RA; Zeifang F; Piacentini L; Kübler W; Rauch B; Niroomand F
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Apr; 353(5):505-12. PubMed ID: 8740143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two site binding of bepridil and modulation of adenylate cyclase in cardiac sarcolemmal membranes.
    Cramb G; Dow JW
    Biochim Biophys Acta; 1983 Dec; 736(1):99-108. PubMed ID: 6317030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of cardiac sarcolemmal adenylate cyclase and sodium, potassium-activated adenosinetriphosphatase activities.
    Tada M; Kirchberger MA; Iorio JM; Katz AM
    Circ Res; 1975 Jan; 36(1):8-17. PubMed ID: 123180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of heart sarcolemmal enzyme activities in normal and cardiomyopathic (UM-X7.1) hamsters.
    Dhalla NS; Singh JN; Bajusz E; Jasmin G
    Clin Sci Mol Med; 1976 Sep; 51(3):233-42. PubMed ID: 134861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial effects of propionyl L-carnitine on sarcolemmal changes in congestive heart failure due to myocardial infarction.
    Sethi R; Dhalla KS; Ganguly PK; Ferrari R; Dhalla NS
    Cardiovasc Res; 1999 Jun; 42(3):607-15. PubMed ID: 10533600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unmasking effect of alamethicin on the (Na+,K+)-ATPase, beta-adrenergic receptor-coupled adenylate cyclase, and cAMP-dependent protein kinase activities of cardiac sarcolemmal vesicles.
    Jones LR; Maddock SW; Besch HR
    J Biol Chem; 1980 Oct; 255(20):9971-80. PubMed ID: 6253461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of palmitoyl carnitine with calcium antagonists in myocytes.
    Patmore L; Duncan GP; Spedding M
    Br J Pharmacol; 1989 Jun; 97(2):443-50. PubMed ID: 2474346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of a GTP-binding protein in coupling of a muscarinic cholinergic receptor and Na,K-ATPase in myocardial sarcolemma].
    Turmukhambetova VK; Danilenko MP; Panchenko MP; Ritov VB; Esyrev OV; Tkachuk VA
    Biokhimiia; 1992 Feb; 57(2):163-73. PubMed ID: 1326337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of vanadium in the +5, +4 and +3 oxidation states on cardiac force of contraction, adenylate cyclase and (Na+ + K+)-ATPase activity.
    Schmitz W; Scholz H; Erdmann E; Krawietz W; Werdan K
    Biochem Pharmacol; 1982 Dec; 31(23):3853-60. PubMed ID: 6297502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac sarcolemmal Na+-K+-ATPase: combined effects of propranolol and arachidonyl CoA.
    Kramer JH; Owens K; Weglicki WB
    Am J Physiol; 1983 May; 244(5):H738-42. PubMed ID: 6303134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of some L-carnitine derivatives on heart membrane ATPases.
    Dhalla NS; Kolár F; Shah KR; Ferrari R
    Cardiovasc Drugs Ther; 1991 Feb; 5 Suppl 1():25-30. PubMed ID: 1851632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [M-cholinoreceptor-mediated inhibition of Na, K-ATPase activity in the myocardial sarcolemma and intestinal smooth muscles by acetylcholine].
    Danilenko MP; Esyrev OV; Omarova RD; Smagulova ZSh; Turmukhambetova VK
    Biull Eksp Biol Med; 1984 Sep; 98(9):259-61. PubMed ID: 6091807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [M-cholinergic regulation of Na+,K+-ATPase activity of vesicular preparations of sarcolemma from the myocardium and intestinal smooth muscles].
    Danilenko MP; Smagulova ZSh; Turmukhambetova VK; Omarova RD; Esyrev OV
    Ukr Biokhim Zh (1978); 1988; 60(1):55-60. PubMed ID: 2834846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sarcolemmal alterations during the development of genetically determined cardiomyopathy.
    Panagia V; Singh JN; Anand-Srivastava MB; Pierce GN; Jasmin G; Dhalla NS
    Cardiovasc Res; 1984 Sep; 18(9):567-72. PubMed ID: 6147191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.